Canify AG is a medical cannabis startup with a mission to provide relief to patients across Europe. The company is in the final stages of becoming a licensed producer and distributor of high-quality medical cannabis products.
Canify AG strictly adheres to European GACP and GMP guidelines, ensuring transparency and traceability throughout the entire production and distribution process. The company also offers services for partners seeking entry into the German medical cannabis market.
Notably, Canify AG prioritizes social and environmental responsibility by maintaining a European value chain, regional supply chain, and internal control over operations to ensure excellence. Establishing a strong foothold in the pharmaceutical and manufacturing industries, the company was founded in 2019. With no available details about the headquarter or recent investments, Canify AG presents an opportunity for potential investors who resonate with its values and seek involvement in cutting-edge medical research and manufacturing excellence.
There is no investment information
No recent news or press coverage available for Canify AG.